EGRP News Flash - October 23, 2008

New NIH Policy to Fund Meritorious Science Earlier

On October 8, 2008, the NIH announced that beginning with original new applications (i.e., never submitted) and competing renewal applications submitted for the January 25, 2009 due dates and beyond, the NIH will accept only a single amendment (A1) to the original application. Failure to receive funding after two submissions (i.e., the original and the single amendment) will mean that the applicant should substantially re-design the project rather than simply change the application in response to previous reviews. It is expected that this policy will lead to funding high quality applications earlier, with fewer resubmissions.

Original new and competing renewal applications that were submitted prior to January 25, 2009 will be permitted two amendments (A1 and A2). For these "grandfathered" applications, NIH expects that any A2 will be submitted no later than January 7, 2011, and NIH will not accept A2 applications after that date.

This policy applies to all applications, including applications submitted under the NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, Career Development Awards, Individual Fellowships, Institutional Training Grants, Resource Grants, Program Projects, and Centers. Currently no amendments are permitted for applications received in response to a Request for Applications (RFA) unless it is specified in the Funding Opportunity Announcement, in which case only one amendment will be permitted.

Applicants are strongly encouraged to discuss their questions with their NIH Institute or Center contact. For additional information or questions, send an email to EnhancingPeerReview@mail.nih.gov or contact:

Division of Receipt and Referral Center for Scientific Review
6701 Rockledge Drive, MSC 7720
Bethesda, MD 20892-7720
Voice: (301) 435-0715
Fax: (301) 480-1987

The new policy was announced in the NIH Guide for Grants and Contracts, NOT-OD-09-003External Web Site Policy.

Return to Top